|
|
|
|
The changing face of clinical trials in the personalized medicine and immuno-oncology era: Report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
|
|
|
|
|
|
|
|
نویسنده
|
golan t. ,milella m. ,ackerstein a. ,berger r.
|
|
منبع
|
journal of experimental and clinical cancer research - 2017 - دوره : 36 - شماره : 1
|
|
چکیده
|
In the past decade,the oncology community has witnessed major advances in the understanding of cancer biology and major breakthroughs in several different therapeutic areas,from solid tumors to hematological malignancies; moreover,the advent of effective immunotherapy approaches,such as immune-checkpoint blockade,is revolutionizing treatment algorithms in almost all oncology disease areas. as knowledge evolves and new weapons emerge in the war against cancer
|
|
کلیدواژه
|
clinical and translational research need to adapt to a rapidly changing environment to effectively translate novel concepts into sustainable and accessible therapeutic options for cancer patients. With this in mind
|
|
آدرس
|
oncology institute,sheba medical center,emek haela st 1,tel hashomer ramat gan,israel,sackler faculty of medicine,tel aviv university,tel aviv, Israel, division of medical oncology 1,regina elena national cancer institute,via elio chianesi 53,rome,00144, Italy, oncology institute,sheba medical center,emek haela st 1,tel hashomer ramat gan, Israel, oncology institute,sheba medical center,emek haela st 1,tel hashomer ramat gan,israel,sackler faculty of medicine,tel aviv university,tel aviv, Israel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|